NHS Cancer 360 tool aims to bring together data on cancer patients in one place, allowing clinicians access to all the information through the Federated Data Platform (FDP).

According to NICE's Early Value Assessment (EVA) guidance on the technology, automated use of DERM "could result in more lesions being correctly identified as non-cancer without a biopsy, compared ...

People check their bank balance more frequently than they do their body for possible warning signs of cancer, an NHS survey has found ... looked for changes to their bodies at least once every three ...

US FDA approves Verastem’s Avmapki Fakzynja combo therapy to treat patients with KRAS-mutated recurrent low-grade serous ovarian cancer: Boston Saturday, May 10, 2025, 13:00 Hrs ...

A quarter of GPs strongly support the NHS introducing prostate cancer screening, but many highlight issues with PSA tests, a ...

Deep vein thrombosis, which is associated with several cancers including urogenital, breast, colorectal and lung cancer. Since NG12 was last updated, non-specific symptom pathways have been rolled out ...

What impact can we expect from the abolition of NHS England (NHSE) and changes at the Department of Health and Social Care ...

The jab is an injectable form of the immunotherapy drug nivolumab, which can be used to treat 15 cancer types, including skin, bladder, and oesophagus cancer ...

It forms part of the NHS Long ... how prostate cancer patients experience SDM in relation to treatment choices, in the first of two articles on a UK-wide study on patient-health professional ...

The NHS has become the first health service in Europe to offer a new cancer jab that dramatically cuts treatment time. Patients will now receive their immunotherapy in just 5 minutes instead of up to ...